3D medical animation services have emerged as a groundbreaking tool in the healthcare industry, revolutionizing the way medical concepts are taught, understood, and marketed. 3D medical animation ...

The vast majority of healthcare organizations have spotted a cyberattack and suffered financial consequences as a result in ...

Opdivo Qvantig, administered by injection in less than five minutes, is now FDA approved for most solid tumor indications covered by Opdivo, a 30-minute intravenous infusion. The new product will ...

Nadim Ahmed has over 25 years of leadership experience in oncology development and commercialization. In his current role as CEO of Cullinan Therapeutics, Nadim oversees an expert team focused on ...

Ransomware attacks on healthcare organizations continue to soar. According to IT Governance USA, the healthcare sector reported 280 cyber incidents as of June 2024. At the halfway point of 2024 ...

Site augmentation emerges as a dynamic response to the growing complexity and volume of clinical trials, and the challenge of limited resources at clinical research sites. This support model ...

3D medical animation services have emerged as a groundbreaking tool in the healthcare industry, revolutionizing the way medical concepts are taught, understood, and marketed. 3D medical animation ...

Thomas Senderovitz, senior vice president of data science at Novo Nordisk, challenges conventional notions about AI and the need for humans in the loop. A new report from Relatient, A Data-Driven ...

China has become a key piece of Foresite Capital’s investment and company formation strategy. During the J.P. Morgan Healthcare Conference, Managing Director Michael Rome shared his thoughts on why ...

If you’ve been in the healthcare space for any length of time, you know the buzz around artificial intelligence (AI) is nothing new. In fact, the act of automating processes to increase ...

ArriVent Biopharma, a company that secures rights to drugs from emerging markets to develop them for Western markets, is adding to its pipeline with a Phase 1-ready drug candidate from China that ...